-+ 0.00%
-+ 0.00%
-+ 0.00%
QUICK SPARK: UnitedHealth Calls 2026 the Bottom for Medicaid Margins
Share
Listen to the news

UnitedHealth Group Inc. (NYSE:UNH) says its Medicaid business is bottoming and expects core Medicaid margins to improving after 2026.

UnitedHealthcare CEO Tim Noel told the company’s third-quarter earnings call that 2026 should be the trough year, now projected to be moderately better than minus 1%. Management said it expects margins to improve in 2027 and reach target levels by 2028.

UnitedHealth’s Medicare Advantage Ratings

Last Friday, shares of health insurance companies, including UnitedHealth, traded higher after the U.S. Centers for Medicare & Medicaid Services (CMS) awarded five- and four-star ratings to plans offered by UnitedHealth, Clover Health Investments Corp (NYSE:CLOV) and Humana Inc. (NYSE:HUM).

This recognition comes as Humana reaffirmed its fiscal year 2026 adjusted EPS guidance and issued optimistic comments about fiscal years 2027 and 2028.

Network Adjustments Amid Rising Costs

To address rising costs, UnitedHealthcare and CVS Health Corp. (NYSE:CVS)‘s Aetna plan to tighten their Medicare Advantage networks by 2027.

In an Oct. 4 note, UnitedHealthcare President Bobby Hunter emphasized the need to respond to systemwide strain, citing higher medical and drug bills.

New Medicare Plans with $0 Premiums

To expand access, UnitedHealthcare introduced its 2027 Advantage plans on Oct. 1, featuring $0 premiums and broader benefits.

The insurer aims to lower out-of-pocket costs and expand plan options for seniors. Over 94% of Medicare-eligible individuals will have access to a UnitedHealthcare plan, and 90% can choose a $0-premium plan.

The rollout includes updated UCard perks and $0 copays for primary care visits and Tier 1 prescription drugs.

Read also

Image: Shutterstock

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending